Suven Pharmaceuticals announces today that the US Food and Drug Administration (USFDA) has issued an EIR for its wholly owned Subsidiary Casper Parma, a finished dosage drug Manufacturer for human use. The pre- approval inspection was conducted during 25 July 22 through 29 July 22. Pre-Approval Inspections covering of three applications: NDA 016084, ANDA 217020, & ANDA 217030. The inspection concluded with no observation (FDA-483) issued. EIR received from US FDA states that the site is recommended for approval of the three NDA & ANDA listed above. Powered by Capital Market - Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.